OnSky Health International makes its company debut with the introduction of SkyPad™, the industry’s first virtual care solution that provides continuous contact-free vital sign sensing with an optional emergency alert and calling service. SkyPad uses machine learning (ML), powered by OnSky Health’s proprietary and custom sensor technology, to accurately sense and monitor users’ vital signs, sleep quality and body motions. With OnSky Health’s companion Emergency D

Zelis, a leading payments company in healthcare, today announced the completion of its previously announced acquisition of Sapphire Digital (“Sapphire”), the healthcare industry’s leading platform for provider selection, patient access, price transparency, and digital consumer navigation. Nearly 100 million people rely on Sapphire to help them discover, select and gain access to the care they need. “This is an exciting day for both companies as we complete th

Check-Cap Ltd., a clinical stage medical diagnostics company advancing the development of C-Scan®, the first and only patient-friendly, preparation-free screening test to detect polyps before they may transform into colorectal cancer (CRC), today announced the expansion of C-Scan's manufacturing capacity and on-premise production line, as well as the remediation of technical issues from a single source supplier. The significant expansion of the Company's production line is intende

Viva Eve The Fibroid Experts™ is thrilled to announce the opening of a new highly advanced fibroid surgical center in Astoria, Queens. The new center is dedicated to treating women with fibroids and performing minimally invasive procedures. "Our new state-of-the-art interventional radiology and gynecology procedure center was designed to provide a space where patients can undergo life-changing innovative procedures that provide lasting symptom relief," says Dr. James A. Gohar,

Sage Growth Partners, a research firm that accelerates commercial success for growth-minded health organizations, today released recent findings from its first Market Report on Data Analytics. Commissioned by InterSystems, an innovative data technology provider dedicated to helping customers solve the most critical information challenges, the study surveyed 100 healthcare organization executives to identify the most common data obstacles and how to address them. According to the research, onl

Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its Embozene® microspheres for genicular artery embolization (GAE) for symptomatic knee osteoarthritis. Embozene is a medical device that is FDA cleared for the embolization of hypervascular tumors, arteriovenous malformations, uterine fibroids and benign prostatic hyperplasia. Embozene microspheres received this des

Haymarket Medical Network today launched Optometry Advisor, a new digital resource that empowers primary eye care physicians with comprehensive clinical, refractive, and pharmaceutical information. OptometryAdvisor.com meets the informational and educational needs of optometrists by offering the same timely and high quality information that clinicians have come to expect from the Haymarket Medical Network. The site will keep clinicians apprised of current academic research, clinical

Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for sepsis testing,1 today announced it has been awarded a national GPO and Value-Based contract with Premier Inc., a leading healthcare improvement company uniting an alliance of approximately 4,400 U.S. hospitals and health systems. Effective December 1, 2021, the new agreement enables Premier members to take advantage of pri

Organon, a global women’s health company, today announced clearance by the U.S. Food and Drug Administration (FDA) of the Special 510(k) for technological updates to the Jada® System, intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The incidence of postpartum hemorrhage due to uterine atony has increased significantly in the United States during the past decade.ii The product updates include a

MITRE has created two new organizations intended to help the company better focus on cybersecurity threats to critical infrastructure and new approaches to public health challenges. The Cyber Infrastructure Protection Innovation Center and Clinical Insights Innovation Cell are part of MITRE Labs, which MITRE established in 2020 to drive breakthroughs in applied science and advanced technology that transform the future of U.S. scientific and economic leadership. “MITR